Ann Woolfrey is an Oncology physician affiliated with Fred Hutch Cancer Center. OpenAlex indexes 221 publications with 12,915 citations (h-index 60); ClinicalTrials.gov lists 9 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Eastlake Ave E
Seattle, WA 981094405
Telephone
206-288-1000Registry record last updated 9 Nov 2012.
Clinical trials
- Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Sponsor: Fred Hutchinson Cancer Center
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Sponsor: Fred Hutchinson Cancer Center
- Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Sponsor: Fred Hutchinson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1995–2016 per NIH RePORTER. The latest:
- Engraftment and in vivo selection of HIV-protected stem cells
Fred Hutchinson Cancer Research Center
FY2016$808,300R01HL116217 - Engraftment and in vivo selection of HIV-protected stem cells
Fred Hutchinson Cancer Research Center
FY2015$792,237R01HL116217 - Hematopoietic Cell Transplant: Platform for Purging the Latent HIV Reservoir
Fred Hutchinson Cancer Research Center
FY2015$188,456U19AI096111
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most
Biology of Blood and Marrow Transplantation
2018 - Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
Biology of Blood and Marrow Transplantation
2017 - Cord-Blood Transplantation in Patients with Minimal Residual Disease
New England Journal of Medicine
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Riddell, MD
Fred Hutch Cancer Center
Sunil Hingorani, MD, PhD
Fred Hutch Cancer Center
Paul Nghiem
Fred Hutch Cancer Center
Soheil Meshinchi, MD, PhD
Fred Hutch Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”